Publication | Closed Access

Novel bifunctional drugs targeting monoamine oxidase inhibition and iron chelation as an approach to neuroprotection in Parkinson?s disease and other neurodegenerative diseases

Medicinal ChemistryNeurodegenerative DiseasesIron ChelationMedicineNeuropharmacologyMonoamine Oxidase InhibitionNeuroprotectionNeuroscienceNeurologyNeurodegenerationPharmacologyNeurochemistryOxidative StressS Disease